ArticleBMC cardiovascular disorders2026
Prevalence and risk factors of echocardiographically suspected pulmonary hypertension in maintenance hemodialysis patients: a retrospective study.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary hypertension (PH) is a prevalent complication in maintenance hemodialysis (MHD) patients, contributing to increased cardiovascular morbidity. This study aimed to determine the prevalence and independent risk factors for echocardiographically suspected PH in a Chinese MHD cohort.
methodsThis single-center retrospective cross-sectional study reviewed 948 MHD patients who underwent transthoracic echocardiography between January 2023 and December 2024. Suspected PH was consistently defined using standardized objective echocardiographic criteria (estimated pulmonary artery systolic pressure > 35 mmHg), with qualitative right-heart markers serving as supportive criteria only when tricuspid regurgitant jets were unmeasurable. Following rigorous data cleaning to remove extreme outliers, a prespecified multivariable logistic regression model-adjusted for core clinical confounders-was used to identify independent predictors.
resultsThe prevalence of echocardiographically suspected PH was 29.7% (282/948). Patients with suspected PH had significantly lower hemoglobin (107.48 ± 23.70 vs. 113.10 ± 23.93 g/L, p = 0.001) and serum albumin (41.79 ± 5.22 vs. 43.03 ± 4.40 g/L, p < 0.001), alongside markedly higher median brain natriuretic peptide levels (414.30 [IQR: 132.46-1466.23] vs. 124.25 [IQR: 50.30-338.54] pg/mL, p < 0.001). After multivariable adjustment for age, sex, diabetes, hypertension, and dialysis vintage, independent predictors included larger left atrial diameter (OR 1.292, 95% CI 1.223-1.364, p < 0.001), lower left ventricular ejection fraction (OR 0.954, 95% CI 0.927-0.981, p = 0.001), history of thrombectomy (OR 2.450, 95% CI 1.249-4.807, p = 0.009), and history of percutaneous transluminal angioplasty (PTA) (OR 1.511, 95% CI 1.014-2.250, p = 0.042).
conclusionEchocardiographically suspected PH affects approximately 30% of Chinese MHD patients. It is significantly and independently associated with left-sided cardiac remodeling and a history of severe vascular access interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.